Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,588 | 3,119 | 1,495 | -1,072 | -3,993 |
| Depreciation Amortization | 1,449 | 842 | 4,336 | 3,083 | 2,125 |
| Income taxes - deferred | 317 | 90 | 789 | 555 | 321 |
| Accounts receivable | 1,606 | 2,032 | -5,284 | -2,124 | -235 |
| Accounts payable and accrued liabilities | -1,155 | -300 | 287 | -908 | -1,854 |
| Other Working Capital | -4,789 | -2,672 | -11,745 | -10,005 | -9,344 |
| Other Operating Activity | 5,116 | 1,207 | 13,756 | 9,112 | 6,690 |
| Operating Cash Flow | $11,132 | $4,318 | $3,634 | $-1,359 | $-6,290 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,250 | -6,000 | -16,752 | -10,002 | -1,001 |
| PPE Investments | -1,623 | -470 | -1,745 | -1,937 | -1,137 |
| Sale Of Investment | N/A | N/A | 1,017 | 1,017 | N/A |
| Investing Cash Flow | $-14,873 | $-6,470 | $-17,480 | $-10,922 | $-2,138 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,763 | 1,228 | 14,680 | 11,983 | 7,997 |
| Common Stock Repurchased | -238 | -238 | N/A | 0 | N/A |
| Financing Cash Flow | $2,525 | $990 | $14,680 | $11,983 | $7,997 |
| Exchange Rate Effect | -277 | -839 | -675 | -441 | -62 |
| Beginning Cash Position | 5,990 | 5,990 | 5,831 | 5,831 | 5,831 |
| End Cash Position | 4,497 | 3,989 | 5,990 | 5,092 | 5,338 |
| Net Cash Flow | $-1,493 | $-2,001 | $159 | $-739 | $-493 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,132 | 4,318 | 3,634 | -1,359 | -6,290 |
| Capital Expenditure | -1,623 | -470 | -1,745 | -1,937 | -1,137 |
| Free Cash Flow | 9,509 | 3,848 | 1,889 | -3,296 | -7,427 |